Enteral Nutrition Market is expected to reach US$ 13,204.19 million by 2030

PRESS RELEASE BY The Insight Partners 31 Oct 2023

Share this press on

Gastrointestinal Disorders Segment to Lead Global Enteral Nutrition Market during 2022–2030

According to our new research study on “Enteral Nutrition Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Application, Age Group, and Distribution Channel,” the market is expected to grow from US$ 8,276.93 million in 2022 to US$ 13,204.19 million by 2030; it is estimated to grow at a CAGR of 6.0% during 2022–2030. The growth of the market is attributed to a rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

Based on application, the enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment accounted for the largest market share in 2022. Further, the oncology segment is anticipated to register the highest CAGR of 7.3% during 2022–2030. According to the Rome Foundation Global study, in 2020, more than 73,000 people in 33 countries and 4 in every 10 adults worldwide suffered from functional gastrointestinal disorders with varying severities. Age-related gastrointestinal problems are more common in the elderly population aged 64 and above. According to the study titled “Gastrointestinal problem among Indian adults: Evidence from a longitudinal aging study in India,” published in 2022, self-reported gastrointestinal disorders prevalence was recorded at ~18%. Gastrointestinal disorders are frequently accompanied by critical illness, which underlines the need for enteral nutrition.

Enteral Nutrition Market, by Region, 2022 (%)

Enteral Nutrition Market Share, Size, Trends and Revenue Forecast 2030

Download Free Sample

Enteral Nutrition Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (General and Disease Specific), Application (Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others), Age Group (Adult and Pediatric), Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Source: The Insight Partners Analysis

Healthcare professionals prescribe patient-tailored nutritional interventions, which include diet counseling sessions, oral supplementation intake, and advice on whether to follow enteral nutrition, depending on the type of cancer treatment (either curative or palliative) as well as the clinical condition and nutritional status of patients. Nutritional support has been broadly advocated as adjunctive therapy to surgery and medical oncotherapy (radiation or chemotherapy for cancer) for various underlying illnesses. Cancer cachexia is a multifactorial syndrome leading constant skeletal muscle mass loss, which cannot be entirely reversed by conventional nutritional support, resulting in progressive functional impairment. Cancer-induced cachexia (CIC) affects up to 80% of advanced-stage cancer patients, specifically those with gastrointestinal, pancreatic, thoracic, and head and neck malignancies. The catabolism of protein, carbohydrates, and fats in the body may also change when tumors are in the stomach, intestines, head, and neck. FortiCare by Nutricia is a nutritional supplement used in the dietary management of CIC patients. FortiCare can be used in the diet of patients who cannot meet their dietary requirements from other foods.

Nestlé, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC are among the leading enteral nutrition market players.

The enteral nutrition market, by product type, is bifurcated into general and disease specific. The enteral nutrition market, by application, is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The enteral nutrition market, by age group, is divided into adult and pediatric. The enteral nutrition market, by distribution channel, is segmented into hospitals pharmacies, retail stores, e-commerce, and others. By geography, the enteral nutrition market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure